You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

TETRABENAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Tetrabenazine, and when can generic versions of Tetrabenazine launch?

Tetrabenazine is a drug marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Apotex, Bionpharma, Chartwell Rx, Dr Reddys, Hetero Labs Ltd V, Hikma, Mylan, Slate Run Pharma, and Sun Pharm. and is included in eleven NDAs.

The generic ingredient in TETRABENAZINE is tetrabenazine. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the tetrabenazine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tetrabenazine

A generic version of TETRABENAZINE was approved as tetrabenazine by HETERO LABS LTD V on February 3rd, 2016.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TETRABENAZINE?
  • What are the global sales for TETRABENAZINE?
  • What is Average Wholesale Price for TETRABENAZINE?
Summary for TETRABENAZINE
Drug patent expirations by year for TETRABENAZINE
Drug Prices for TETRABENAZINE

See drug prices for TETRABENAZINE

Recent Clinical Trials for TETRABENAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
H. Lundbeck A/SPhase 4
William Ondo, MDPhase 4
The University of Texas Health Science Center, HoustonPhase 4

See all TETRABENAZINE clinical trials

Pharmacology for TETRABENAZINE
Medical Subject Heading (MeSH) Categories for TETRABENAZINE
Anatomical Therapeutic Chemical (ATC) Classes for TETRABENAZINE

US Patents and Regulatory Information for TETRABENAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc TETRABENAZINE tetrabenazine TABLET;ORAL 206686-001 Jul 7, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Slate Run Pharma TETRABENAZINE tetrabenazine TABLET;ORAL 213316-001 Jan 22, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bionpharma TETRABENAZINE tetrabenazine TABLET;ORAL 208826-002 Dec 18, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex TETRABENAZINE tetrabenazine TABLET;ORAL 206093-001 Mar 17, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd V TETRABENAZINE tetrabenazine TABLET;ORAL 204574-001 Feb 3, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm TETRABENAZINE tetrabenazine TABLET;ORAL 206129-001 Aug 17, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.